Medication-related emergency department visits in pediatrics: a prospective observational study

Peter J Zed1, Karen J L Black2, Eleanor A Fitzpatrick3

  • 1Faculty of Pharmaceutical Sciences, Department of Emergency Medicine, Faculty of Medicine, and peter.zed@ubc.ca.

Pediatrics
|February 4, 2015
PubMed

Insights

Medication-related visits (MRVs) account for 8% of pediatric emergency department (ED) visits, with two-thirds preventable. These visits increase hospital admission rates and length of stay for children.

Area of Science:

  • Pediatric Emergency Medicine
  • Pharmacovigilance
  • Public Health

Background:

  • Limited data exist on the frequency and characteristics of medication-related visits (MRVs) to emergency departments (EDs) in pediatric populations.
  • Understanding these events is crucial for improving medication safety in children.

Purpose of the Study:

  • To evaluate the frequency, severity, preventability, and classification of MRVs in pediatric patients presenting to the ED.
  • To identify common causes of MRVs in children.

Main Methods:

  • A prospective observational study was conducted over 12 months.
  • Pediatric patients presenting to the ED were assessed for MRVs using pharmacist and emergency physician evaluations, with independent adjudication.

Main Results:

  • Of 2028 enrolled patients, 8.0% had an MRV, with 65.0% deemed preventable.
  • The most common causes were adverse drug reactions (26.4%), subtherapeutic dosage (19.0%), and nonadherence (17.2%).
  • MRVs were associated with a significantly higher likelihood of hospital admission (OR, 6.5) and longer hospital stays.

Conclusions:

  • Medication-related causes account for approximately 1 in 12 pediatric ED visits, with a majority being preventable.
  • Pediatric patients with MRVs are more likely to be admitted and experience extended hospital stays.
Abstract

Related Concept Videos